Correspondence 0001193125-24-008940 from VACCINEX, INC. (VCNX) (CIK 0001205922) (VCNX)
VACCINEX, INC. (VCNX) (CIK 0001205922)
Date: Jan. 17, 2024 · CIK: 0001205922 · Accession: 0001193125-24-008940
AI Filing Summary & Sentiment
File numbers found in text: 333-276465
Letter
Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester, New York 14620
January 17, 2024
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Vaccinex, Inc.
Registration Statement on Form S-3
Filed January 10, 2024
File No. 333-276465
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Vaccinex, Inc. hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and declare the Registration Statement effective as of 8:30 a.m., Eastern Time, on January 19, 2024, or as soon thereafter as possible.
Please feel free to direct any questions or comments concerning this request to William Intner of Hogan Lovells US LLP at (410) 659-2778, and once the Registration Statement has been declared effective, please notify Mr. Intner by calling him at the same phone number.
Very truly yours,
Vaccinex, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Vaccinex, Inc. 1895 Mount Hope Avenue Rochester, New York 14620 January 17, 2024 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Vaccinex, Inc. Registration Statement on Form S-3 Filed January 10, 2024 File No. 333-276465 Request for Acceleration of Effectiveness Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Vaccinex, Inc. hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and declare the Registration Statement effective as of 8:30 a.m., Eastern Time, on January 19, 2024, or as soon thereafter as possible. Please feel free to direct any questions or comments concerning this request to William Intner of Hogan Lovells US LLP at (410) 659-2778, and once the Registration Statement has been declared effective, please notify Mr. Intner by calling him at the same phone number. Very truly yours, Vaccinex, Inc. /s/ Scott E. Royer By: Scott E. Royer Title: Chief Financial Officer